Table 2:
Study sample characteristics by hepatic steatosis status
| Hepatic steatosis (n = 425) | No hepatic steatosis (n = 2057) | Overall (n = 2482) | |
|---|---|---|---|
| Demographic characteristics and covariates | |||
| Age (years) | 52±11 | 51±10 | 51±11 |
| Sex (women) | 192 (45) | 1075 (52) | 1267 (51) |
| Body Mass Index (BMI, kg/m2) | 31±6 | 27±5 | 28±5 |
| Current smoking | 47 (11) | 233 (11) | 280 (11) |
| Former smoking | 183 (43) | 773 (38) | 956 (39) |
| Cardiovascular disease | 43 (10) | 126 (6) | 169 (7) |
| Regular aspirin use | 107 (25) | 379 (18) | 486 (20) |
| Alcoholic drinks per week | 3.1±3.9 | 3.0±3.4 | 3.0±3.5 |
| Diabetes | 61 (14) | 101 (5) | 162 (7) |
| Fasting glucose (mg/dL) | 108±33 | 97±19 | 99±22 |
| Hypertension | 192/424 (45) | 486/2055 (24) | 678/2479 (27) |
| Lipid lowering therapy | 84 (20) | 249 (12) | 333 (13) |
| Total cholesterol (mg/dl) | 197±36 | 194±35 | 195±35 |
| High-density lipoprotein (HDL) cholesterol (mg/dl) | 45±14 | 54±16 | 52±16 |
| Triglycerides (mg/dl) | 180±115 | 115±75 | 126±87 |
| Alanine aminotransferase (ALT, U/L) | 34.1±25.8 | 23.1±15.8 | 25.0±18.4 |
| Visceral adipose tissue (VAT, cm3) | 2626±1049 | 1565±912 | 1747±1019 |
Mean±standard deviation for continuous variables or n (%) for categorical variables
Hepatic steatosis defined by Liver:Phantom Ratio ≤ 0.33
See Methods for covariate definitions